KASHIV PHARMA LLC
Patent Applications and Registrations
Patent applications and USPTO patent grants for KASHIV PHARMA LLC.The latest application filed is for "gastroretentive dosage forms for sustained drug delivery".
- KASHIV PHARMA LLC - Bridgewater NJ US
- KASHIV PHARMA LLC. - Bridgewater NJ US
- Kashiv Pharma, LLC - Piscataway NJ US
Trademarks
| Patent | Date |
|---|---|
| Opioid agonist / antagonist combination dosage forms Grant 10,960,001 - Shah , et al. March 30, 2 | 2021-03-30 |
| Medicament applicator Grant 10,940,300 - Mellejor , et al. March 9, 2 | 2021-03-09 |
| Gastroretentive dosage forms for sustained drug delivery Grant 10,918,597 - Meghpara , et al. February 16, 2 | 2021-02-16 |
| Gastroretentive Dosage Forms For Sustained Drug Delivery App 20200337998 - Meghpara; Kanji ; et al. | 2020-10-29 |
| Opioid Agonist / Antagonist Combination Dosage Forms App 20190358221 - Shah; Navnit H. ; et al. | 2019-11-28 |
| Extended Release Drug Formulation With Overdose Protection And Abuse Deterrence App 20190282508 - Shah; Navnit H. ; et al. | 2019-09-19 |
| Orally Disintegrating Tablet Formulation For Enhanced Bioavailability App 20190083403 - Djordjevic; Jelena ; et al. | 2019-03-21 |
| Overdose Protection And Abuse Deterrent Immediate Release Drug Formulation App 20190054031 - Shah; Navnit H. ; et al. | 2019-02-21 |
| Orally disintegrating tablet formulation for enhanced bioavailability Grant 10,195,150 - Djordjevic , et al. Fe | 2019-02-05 |
| Surfactant-free Hiv Protease Inhibitor Composition And Method Of Manufacturing Thereof App 20190030006 - Shah; Navnit H. ; et al. | 2019-01-31 |
| Enhanced Abuse-deterrent Formulations Of Oxycodone App 20180303757 - Banerjee; Siddhartha ; et al. | 2018-10-25 |
| Food Independent Immediate Release Drug Formulation With Abuse Deterrence And Overdose Protection App 20180296486 - Shah; Navnit H. ; et al. | 2018-10-18 |
| Surfactant-free HIV protease inhibitor composition and method of manufacturing thereof Grant 10,034,865 - Shah , et al. July 31, 2 | 2018-07-31 |
| Medicament Applicator App 20180154125 - Mellejor; Jamelo J. ; et al. | 2018-06-07 |
| Medicament applicator Grant 9,884,173 - Mellejor , et al. February 6, 2 | 2018-02-06 |
| Method Of Manufacturing Fine Particles Suitable For Orally Disintegrating Pharmaceutical Dosage Forms App 20170173157 - VAKA; Siva Ram Kiran ; et al. | 2017-06-22 |
| Surfactant-free Hiv Protease Inhibitor Composition And Method Of Manufacturing Thereof App 20170071915 - SHAH; NAVNIT H. ; et al. | 2017-03-16 |
| Medicament Applicator App 20170050007 - Mellejor; Jamelo J. ; et al. | 2017-02-23 |
| Medicament applicator Grant 9,517,328 - Mellejor , et al. December 13, 2 | 2016-12-13 |
| Self-nanoemulsion of poorly soluble drugs Grant 9,511,078 - Desai , et al. December 6, 2 | 2016-12-06 |
| Abuse-resistant Drug Formulations With Built-in Overdose Protection App 20160346274 - Vaka; Siva Ram Kiran ; et al. | 2016-12-01 |
| Abuse-resistant Drug Formulations App 20160317530 - Sandhu; Harpreet Kaur ; et al. | 2016-11-03 |
| Self-nanoemulsion Of Poorly Soluble Drugs App 20160151392 - Desai; Dipen ; et al. | 2016-06-02 |
| Orally Disintegrating Tablet Formulation For Enhanced Bioavailability App 20160120809 - Djordjevic; Jelena ; et al. | 2016-05-05 |
| Supersaturated Stabilized Nanoparticles For Poorly Soluble Drugs App 20150335753 - Desai; Dipen ; et al. | 2015-11-26 |
| Medicament Applicator App 20140378948 - Mellejor; Jamelo J. ; et al. | 2014-12-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 